Drug development perspectives considerations, challenges, and strategies

药物研发的展望、考量、挑战和策略

阅读:1

Abstract

Targeted protein degradation (TPD) has garnered appreciable interest in drug discovery due to its unique mechanism of action – degradation of a target in an event-driven manner, instead of traditional occupancy-driven inhibitor-based therapies. This is achieved by employing mono- or hetero-bifunctional small molecules known as degraders or “PROTACs” to induce the proximity of two proteins: a target protein and an E3 ubiquitin ligase, ultimately resulting in clearance of the target protein by the cell’s inherent degradation machinery. A critical step in this pathway is ternary complex formation (TCF) between the ligase, degrader molecule, and the target protein. This presentation will demonstrate the implementation of analytical ultracentrifugation (AUC) for obtaining critical attributes of the degrader system. Beyond thermodynamic and kinetic insights, structural information is attainable, including conformational changes upon binary complex formation and characterization of the important ternary complex. Used in conjunction with hydrodynamic modeling, AUC can help confirm the solution-state structure based on predictive or existing structural data. AUC is a powerful screening tool for degrader-induced ternary complex formation. Once a desirable degrader molecule is identified, a highly rigorous solution-state analysis may be performed to evaluate thermodynamic and structural aspects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。